MedPath

新疆生化药业有限公司

Ownership
-
Established
2002-06-03
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Pediatric paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules

Product Name
小儿氨酚黄那敏颗粒
Approval Number
国药准字H65020351
Approval Date
Feb 5, 2024
NMPA

Benactyzine Methobromide Tablets

Product Name
甲溴贝那替秦片
Approval Number
国药准字H65020371
Approval Date
Feb 5, 2024
NMPA

Paracetamol,Aminophenazone,Caffeine and Chlorphenamine Maleate Tablets

Product Name
酚氨咖敏片
Approval Number
国药准字H65020347
Approval Date
Feb 5, 2024
NMPA

Lamb's Tripe Extract and Vitamin B12 Granules

Product Name
羔羊胃提取物维B12颗粒
Approval Number
国药准字H20140012
Approval Date
Jan 9, 2024
NMPA

Difenidol Hydrochloride Tablets

Product Name
盐酸地芬尼多片
Approval Number
国药准字H65020131
Approval Date
Jul 20, 2022
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H65020379
Approval Date
Jul 20, 2022
NMPA

Tabellae Acidi Acetyls Alicylici Compositae

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H65020118
Approval Date
Jul 20, 2022
NMPA

Pyrantel Pamoate Tablets

Product Name
双羟萘酸噻嘧啶片
Approval Number
国药准字H65020125
Approval Date
Jul 20, 2022
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H65020130
Approval Date
Jul 20, 2022
NMPA

Sulfamethoxazole Tablets

Product Name
磺胺甲噁唑片
Approval Number
国药准字H65020122
Approval Date
Jul 20, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.